Related Experiment Video
Updated: Apr 3, 2026
12:08
Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
19.8K
A Mixture Dose-Response Model for Identifying High-Dimensional Drug Interaction Effects on Myopathy Using Electronic
1Center for Computational Biology and Bioinformatics, Indiana University School of Medicine Indianapolis, Indiana, USA ; Department of Biostatistics, Indiana University School of Medicine Indianapolis, Indiana, USA.
CPT: Pharmacometrics & Systems Pharmacology
|September 18, 2015
Summary
Identifying drug combinations that increase myopathy risk is crucial. This study developed a statistical model to pinpoint high-dimensional drug interactions associated with elevated myopathy risk, revealing a dose-response relationship.
Area of Science:
- Pharmacovigilance
- Biostatistics
- Computational Biology
Background:
- Drug interactions pose significant risks of adverse effects, varying in severity across combinations.
- Existing models may not fully capture the complex risk profiles of multi-drug interactions.
Purpose of the Study:
- To develop and apply a statistical model for identifying high-dimensional drug combinations associated with myopathy risk.
- To investigate the dose-response relationship between the number of interacting drugs and myopathy risk.
Main Methods:
- Utilized a novel mixture model combining constant and dose-response risk components.
- Employed an empirical Bayes estimation method on medical record data.
- Analyzed high-dimensional drug interactions (two to six drugs).
Main Results:
- Successfully identified specific high-dimensional drug combinations linked to excessive myopathy risk.
- Achieved significantly low local false-discovery rates for identified interactions.
- Observed a clear dose-response trend: myopathy risk increases with the number of interacting drugs.
Conclusions:
- The study presents the first observed and extracted dose-response relationship for high-dimensional drug interactions from real-world medical data.
- The developed statistical model effectively identifies drug combinations posing a substantial myopathy risk.
- Findings highlight the importance of considering the cumulative effect of multiple drug interactions in patient safety.
Related Concept Videos
01:09Pharmacodynamic Models: Additive and Proportional Drug Effect Model
67
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
67
01:29Pharmacodynamic Models: Direct Effect Model and Indirect Response Model
116
Pharmacodynamic models are essential tools in understanding the relationship between drug concentrations and their effects on biological systems. By characterizing the dynamics of drug action, these models guide dose selection, optimize therapeutic efficacy, and inform the development of new drugs. Two major classes of pharmacodynamic models include direct effect and indirect response models.Direct Effect ModelsDirect effect models describe the immediate relationship between drug concentration...
116
01:15Pharmacodynamic Models: Linear Concentration–Effect Model
57
The linear concentration–effect model, underpinned by the principle that pharmacological effect (E) is directly proportional to plasma drug concentration (C), emerges as a pivotal simplification of the Emax model for conditions where C is significantly less than EC50. This model portrays a linear trajectory of the concentration–effect relationship when drug levels are markedly below the EC50 threshold.Despite its inherent assumption of continuous effect augmentation with increasing...
57
01:24Pharmacokinetic–Pharmacodynamic Relationship: Problems
79
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
79
01:26Pharmacokinetic–Pharmacodynamic Relationship: Exposure, Response and Effect
205
The pharmacokinetic-pharmacodynamic (PK-PD) relationship describes the intricate link between drug exposure, efficacy, and toxicity, forming the foundation for optimal dosing regimens. This relationship uses mathematical modeling to characterize drug concentration-effect dynamics, ensuring precise therapeutic outcomes.Exposure represents the pharmacokinetic aspect of the PK-PD relationship, denoting the drug amount that elicits a biological response. It is typically quantified by administered...
205
01:18Pharmacodynamic Models: Emax Drug–Concentration Effect Model
141
The Emax drug-concentration effect model is central to pharmacodynamics in drug discovery and development. This model is predicated on the receptor occupancy theory, which posits that the effect of a drug is directly related to the number of receptors occupied by the drug and the resultant complex formation.The model describes the reversible interaction between a drug (C) and a receptor (R) to form a drug-receptor complex (RC). The kinetics of this interaction are quantified by an equation that...
141